Institutional investors purchased a net $10.2 million shares of IMMU during the quarter ended December 2016, and now own 60.20% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VENBIO SELECT ADVISOR LLC Bought 1.2 Million shares of Immunomedics Inc
ARCTIC FUND MANAGEMENT AS (SWEDE... Bought 633.5 Thousand shares of Immunomedics Inc
CANDRIAM LUXEMBOURG SA Bought 510.0 Thousand shares of Immunomedics Inc